Celecoxib-Induced Gastrointestinal, Liver and Brain Lesions in Rats, Counteraction by BPC 157 or L-Arginine, Aggravation by L-NAME
Until rigorous, randomized, placebo-controlled trials are conducted and published, the responsible position is to rely on proven, evidence-based approaches to recovery and healing, and to leave unapproved peptides where they belong for now: in the laboratory, not in your body.
In a clinical or wellness setting, BPC-157 therapy is provided as part of a provider-supervised treatment plan focused on recovery support, injury management, and overall physical wellness
It is sold as a research peptide for laboratory investigation only and is not an approved veterinary medicine
Saunders Co